{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:48:26Z","timestamp":1792604906237,"version":"4.5.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068635"],"award-info":[{"award-number":["UM1AI068635"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068618"],"award-info":[{"award-number":["UM1AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068614"],"award-info":[{"award-number":["UM1AI068614"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0226803","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T13:39:36Z","timestamp":1580391576000},"page":"e0226803","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans"],"prefix":"10.1371","volume":"15","author":[{"given":"Lue Ping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7627-2166","authenticated-orcid":true,"given":"Andrew","family":"Fiore-Gartland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-5925","authenticated-orcid":true,"given":"Lindsay N.","family":"Carpp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen W.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llewellyn","family":"Fleurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-7121","authenticated-orcid":true,"given":"One","family":"Dintwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-2001","authenticated-orcid":true,"given":"Zoe","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-234X","authenticated-orcid":true,"given":"Nigel","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6872-5687","authenticated-orcid":true,"given":"Craig","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-984X","authenticated-orcid":true,"given":"Holly E.","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorachai","family":"Nitayaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnee","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supachai","family":"Rerks-Ngarm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-5774","authenticated-orcid":true,"given":"Glenda E.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-3270","authenticated-orcid":true,"given":"Kelly E.","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"pone.0226803.ref001","unstructured":"UNAIDS. UNAIDS data 2018. Available from: http:\/\/www.unaids.org\/en\/resources\/documents\/2018\/unaids-data-2018."},{"issue":"15","key":"pone.0226803.ref002","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1073\/pnas.1703236114","article-title":"Preventing acquisition of HIV is the only path to an AIDS-free generation","volume":"114","author":"L Corey","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"pone.0226803.ref003","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1073\/pnas.1620788114","article-title":"Effectiveness of UNAIDS targets and HIV vaccination across 127 countries","volume":"114","author":"J Medlock","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"pone.0226803.ref004","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/infdis\/jiu568","article-title":"Increasing Complexity of Vaccine Development","volume":"212","author":"SA Plotkin","year":"2015","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0226803.ref005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"NM Flynn","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"pone.0226803.ref006","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"P Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"issue":"9653","key":"pone.0226803.ref007","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"pone.0226803.ref008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"pone.0226803.ref009","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"pone.0226803.ref010","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"SM Hammer","year":"2013","journal-title":"N Engl J Med"},{"issue":"13","key":"pone.0226803.ref011","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/JVI.03070-12","article-title":"Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial","volume":"87","author":"GH Kijak","year":"2013","journal-title":"J Virol"},{"issue":"8","key":"pone.0226803.ref012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/aid.2006.22.801","article-title":"Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping","volume":"22","author":"V Watanaveeradej","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"14","key":"pone.0226803.ref013","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0226803.ref014","doi-asserted-by":"crossref","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"S Zolla-Pazner","year":"2014","journal-title":"PLoS One"},{"issue":"22","key":"pone.0226803.ref015","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"GD Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0226803.ref016","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"L Lin","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"228","key":"pone.0226803.ref017","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"NL Yates","year":"2014","journal-title":"Sci Transl Med"},{"issue":"4","key":"pone.0226803.ref018","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology","volume":"163","author":"AW Chung","year":"2015","journal-title":"Cell"},{"issue":"15","key":"pone.0226803.ref019","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1128\/JVI.01164-14","article-title":"Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial","volume":"88","author":"AJ Gartland","year":"2014","journal-title":"J Virol"},{"issue":"296","key":"pone.0226803.ref020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/scitranslmed.aab4005","article-title":"HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition","volume":"7","author":"HA Prentice","year":"2015","journal-title":"Sci Transl Med"},{"issue":"9","key":"pone.0226803.ref021","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1172\/JCI75539","article-title":"FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial","volume":"124","author":"SS Li","year":"2014","journal-title":"J Clin Invest"},{"issue":"8","key":"pone.0226803.ref022","doi-asserted-by":"crossref","first-page":"e103446","DOI":"10.1371\/journal.pone.0103446","article-title":"Predictors of HVTN 503 MRK-AD5 HIV-1 gag\/pol\/nef vaccine induced immune responses","volume":"9","author":"KL Hopkins","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"pone.0226803.ref023","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1086\/425518","article-title":"Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines","volume":"190","author":"DC Montefiori","year":"2004","journal-title":"J Infect Dis"},{"issue":"20","key":"pone.0226803.ref024","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.vaccine.2015.03.036","article-title":"Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials","volume":"33","author":"X Jin","year":"2015","journal-title":"Vaccine"},{"issue":"S1","key":"pone.0226803.ref025","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1089\/aid.2014.5052a.abstract","article-title":"HVTN 097: Evaluation of the RV144 vaccine regimen in HIV uninfected South African adults","volume":"30","author":"GE Gray","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"pone.0226803.ref026","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2352-3018(18)30071-7","article-title":"Subtype C ALVAC-HIV and bivalent subtype C gp120\/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1\/2 trial","volume":"5","author":"LG Bekker","year":"2018","journal-title":"Lancet HIV"},{"issue":"9653","key":"pone.0226803.ref027","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"pone.0226803.ref028","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imr.12503","article-title":"Systems serology for evaluation of HIV vaccine trials","volume":"275","author":"ME Ackerman","year":"2017","journal-title":"Immunol Rev"},{"key":"pone.0226803.ref029","article-title":"Big Data Bioinformatics","author":"CS Greene","year":"2014","journal-title":"Journal of cellular physiology"},{"key":"pone.0226803.ref030","unstructured":"World Health Organization. Global Health Observatory (GHO) data: HIV\/AIDS 2018 [Feb 6, 2018]. Available from: www.who.int\/gho\/hiv\/en\/."},{"issue":"5","key":"pone.0226803.ref031","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"A deCamp","year":"2014","journal-title":"J Virol"},{"issue":"8","key":"pone.0226803.ref032","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01843-17","article-title":"HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees","volume":"92","author":"NL Yates","year":"2018","journal-title":"J Virol"},{"issue":"S1","key":"pone.0226803.ref033","first-page":"OA14.04","article-title":"The Relationship between Immune Responses to Tetanus Vaccine, Hepatitis B Vaccine and a Pox-protein HIV Vaccine Regimen","volume":"32","author":"Y Huang","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"24","key":"pone.0226803.ref034","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"GD Tomaras","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"pone.0226803.ref035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cyto.a.22590","article-title":"OMIP-025: evaluation of human T- and NK-cell responses including memory and follicular helper phenotype by intracellular cytokine staining","volume":"87","author":"G Moncunill","year":"2015","journal-title":"Cytometry A"},{"key":"pone.0226803.ref036","article-title":"HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens","author":"X Shen","year":"2020","journal-title":"Scientific Reports"},{"key":"pone.0226803.ref037","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3324-9","volume-title":"Density estimation for statistics and data analysis","author":"BW Silverman","year":"1986"},{"issue":"377","key":"pone.0226803.ref038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1982.10477788","article-title":"An Analysis of Transformations Revisited, Rebutted","volume":"77","author":"GEP Box","year":"1982","journal-title":"J Am Stat Assoc"},{"key":"pone.0226803.ref039","first-page":"713","volume-title":"Encyclopedia of Biostatistics","author":"BS Everitt","year":"1998"},{"issue":"21","key":"pone.0226803.ref040","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1002\/sim.6952","article-title":"Power\/sample size calculations for assessing correlates of risk in clinical efficacy trials","volume":"35","author":"PB Gilbert","year":"2016","journal-title":"Stat Med"},{"issue":"2","key":"pone.0226803.ref041","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/biom.12812","article-title":"Covariate-adjusted Spearman's rank correlation with probability-scale residuals","volume":"74","author":"Q Liu","year":"2018","journal-title":"Biometrics"},{"issue":"4","key":"pone.0226803.ref042","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/cjs.11302","article-title":"Probability-scale residuals for continuous, discrete, and censored data","volume":"44","author":"BE Shepherd","year":"2016","journal-title":"Can J Stat"},{"issue":"2","key":"pone.0226803.ref043","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/biomet\/asr073","article-title":"A new residual for ordinal outcomes","volume":"99","author":"C Li","year":"2012","journal-title":"Biometrika"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T13:40:00Z","timestamp":1580391600000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226803"}},"subtitle":[],"editor":[{"given":"Joseph J.","family":"Mattapallil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0226803","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}